Laing Nigel G, Clarke Nigel F, Dye Danielle E, Liyanage Khema, Walker Kendall R, Kobayashi Yasuaki, Shimakawa Shuichi, Hagiwara Tohru, Ouvrier Robert, Sparrow John C, Nishino Ichizo, North Kathryn N, Nonaka Ikuya
Centre for Neuromuscular and Neurological Disorders, University of Western Australia.
Ann Neurol. 2004 Nov;56(5):689-94. doi: 10.1002/ana.20260.
We report three heterozygous missense mutations of the skeletal muscle alpha actin gene (ACTA1) in three unrelated cases of congenital fiber type disproportion (CFTD) from Japan and Australia. This represents the first genetic cause of CFTD to be identified and confirms that CFTD is genetically heterogeneous. The three mutations we have identified Leucine221Proline, Aspartate292Valine, and Proline332Serine are novel. They have not been found previously in any cases of nemaline, actin, intranuclear rod, or rod-core myopathy caused by mutations in ACTA1. It remains unclear why these mutations cause type 1 fiber hypotrophy but no nemaline bodies. The three mutations all lie on one face of the actin monomer on the surface swept by tropomyosin during muscle activity, which may suggest a common pathological mechanism. All three CFTD cases with ACTA1 mutations had severe congenital weakness and respiratory failure without ophthalmoplegia. There were no clinical features specific to CFTD cases with ACTA1 mutations, but the presence of normal eye movements in a severe CFTD patient may be an important clue for the presence of a mutation in ACTA1.
我们报告了来自日本和澳大利亚的三例先天性纤维类型不均衡(CFTD)非亲缘病例中骨骼肌α肌动蛋白基因(ACTA1)的三个杂合错义突变。这是首次鉴定出的CFTD的遗传病因,并证实CFTD在遗传上具有异质性。我们鉴定出的三个突变,即亮氨酸221脯氨酸、天冬氨酸292缬氨酸和脯氨酸332丝氨酸,都是新发现的。它们此前未在任何由ACTA1突变引起的杆状、肌动蛋白、核内杆状或杆状核心肌病病例中被发现。目前尚不清楚为什么这些突变会导致1型纤维萎缩但不形成杆状体。这三个突变均位于肌肉活动期间原肌球蛋白扫过的肌动蛋白单体的同一面上,这可能提示存在一种共同的病理机制。所有三例携带ACTA1突变的CFTD病例均有严重的先天性肌无力和呼吸衰竭,无眼肌麻痹。携带ACTA1突变的CFTD病例没有特异性临床特征,但严重CFTD患者存在正常的眼球运动可能是存在ACTA1突变的重要线索。